Active Surveillance in Frontline Management of Desmoid Tumors

Author(s):

Jonathan C. Trent, MD, PhDMark Agulnik, MD

A panel of oncology experts examine the significance of employing active surveillance as a primary strategy in the treatment of desmoid tumors, providing expert insights into this approach.

EP: 1.An Overview of the Landscape Surrounding Desmoid Tumors

EP: 2.Expert Perspectives on the Pathogenesis and Diagnosis of Desmoid Tumors

EP: 3.Signs and Symptoms of Desmoid Tumors and Their Impact on Quality of Life

Now Viewing

Active Surveillance in Frontline Management of Desmoid Tumors

EP: 1.An Overview of the Landscape Surrounding Desmoid Tumors

EP: 2.Expert Perspectives on the Pathogenesis and Diagnosis of Desmoid Tumors

EP: 3.Signs and Symptoms of Desmoid Tumors and Their Impact on Quality of Life

EP: 4.Active Surveillance in Frontline Management of Desmoid Tumors

EP: 5.The Evolving Role of Surgery in the Management of Desmoid Tumors

EP: 6.Treatment Strategies Using Radiotherapy or Other Locoregional Approaches in Desmoid Tumors

EP: 7.Approaches to Systemic Therapy in Desmoid Tumors: The Role of Chemotherapy

EP: 8.The Role of Supportive Care Measures in Patients with Desmoid Tumors

EP: 9.Desmoid Tumors in Women: Special Considerations for Pregnancy and Contraception

EP: 10.Targeting NOTCH Pathway Signaling with Nirogacestat

EP: 11.DeFi: Nirogacestat in Patients with Progressing Desmoid Tumors

EP: 12.Impact of Nirogacestat on Pain, Quality of Life, and Fertility in Patients with Desmoid Tumors

EP: 13.Nirogacestat's Impact on the Future Treatment of Desmoid Tumors

EP: 14.Future Perspectives on the Treatment of Desmoid Tumors

Latest Conference Coverage